Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A low grade glioma is a type of tumor that forms in the brain and spinal cord. It is a primary tumor, meaning it develops in the brain or spinal cord rather than spreading from elsewhere in the body.
Low grade gliomas begin in the glue-like glial cells that surround nerve cells and help them function. A low grade glioma is an overgrowth of glial cells.
U.S. doctors diagnose 2,000 to 3,000 people with low grade glioma each year, making it one of the most common primary brain tumors.
Our doctors use 3 main categories of treatment for gliomas: surgery, radiation therapy, and drug therapy. We often recommend a combination of these treatments, based on the specific details discovered during diagnosis. You and your doctor work together to identify the best option for you, based on factors such as:
Size of the tumor
Aggressiveness of the cancer
When making recommendations, your Stanford doctors can choose from a range of specialized diagnostic and treatment approaches, including for tissue sampling (biopsy) and surgery.
Improvements in imaging technology, for example, have provided surgeons with valuable tools to locate, identify, and learn more about brain tumors. These image-guided approaches allow them to “map” the brain and separate tumors from healthy tissue. They can also perform safer, less-invasive procedures. Your team will work with you to identify the best option for you.
Clinical trials evaluate new approaches, devices, or medications in the treatment of gliomas. Ask your doctor or clinical trials coordinator about available trials that may be additional options for your care.
To learn more about the clinical trials we offer, contact Sophie Bertrand at 650-723-4467.